Abigail Fagan
From this contributor
New measure yields rapid diagnosis in adults with autism
An abbreviated tool enables clinicians to quickly assess adults for signs of autism.
New measure yields rapid diagnosis in adults with autism
New York program transports children with autism to their passion
In a New York City after-school program, children with autism build social skills through a shared interest in trains.
New York program transports children with autism to their passion
Tool taps personal interests to understand self-control
A novel take on a widely used test could help clinicians assess impulsivity in people with autism.
Tool taps personal interests to understand self-control
Anxiety may heighten social communication challenges in autism
Anxiety may exacerbate social communication problems in children with autism — and not the other way around.
Anxiety may heighten social communication challenges in autism
Marijuana compound curbs seizures by pushing ‘brakes’ in brain
A compound derived from marijuana may treat a severe form of epilepsy by dampening brain activity.
Marijuana compound curbs seizures by pushing ‘brakes’ in brain
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.